Natixis Advisors LLC reduced its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 8.8% in the 4th quarter, HoldingsChannel reports. The fund owned 180,125 shares of the company’s stock after selling 17,379 shares during the quarter. Natixis Advisors LLC’s holdings in McKesson were worth $147,755,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. GGM Financials LLC acquired a new stake in shares of McKesson in the 3rd quarter valued at about $25,000. State of Wyoming acquired a new stake in shares of McKesson in the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson in the 3rd quarter valued at about $31,000. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of McKesson in the 3rd quarter valued at about $33,000. Finally, Board of the Pension Protection Fund acquired a new stake in shares of McKesson in the 4th quarter valued at about $33,000. 85.07% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, EVP Thomas L. Rodgers sold 2,388 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total value of $1,817,482.92. Following the completion of the transaction, the executive vice president directly owned 3,090 shares of the company’s stock, valued at $2,351,768.10. This trade represents a 43.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Michele Lau sold 3,550 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total value of $2,701,869.50. Following the completion of the transaction, the executive vice president directly owned 3,247 shares of the company’s stock, valued at $2,471,259.23. The trade was a 52.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.08% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Analysis on MCK
McKesson Trading Down 0.8%
Shares of MCK stock opened at $736.73 on Tuesday. The company has a market cap of $88.56 billion, a price-to-earnings ratio of 19.15, a price-to-earnings-growth ratio of 1.11 and a beta of 0.35. The stock has a 50 day simple moving average of $816.69 and a 200-day simple moving average of $851.56. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00.
McKesson (NYSE:MCK – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. The business had revenue of $96.30 billion during the quarter, compared to the consensus estimate of $101.35 billion. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The company’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the prior year, the business posted $10.12 EPS. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, equities analysts forecast that McKesson Corporation will post 44.29 earnings per share for the current fiscal year.
McKesson Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be paid a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson’s dividend payout ratio is 8.53%.
McKesson Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Featured Articles
- Five stocks we like better than McKesson
- Why 1 Little-Known ETF Is Riding the AI Chip Shortage
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
